The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Jakubowiak — Advisory Committee (AC): Millennium Pharmaceuticals Inc; Consulting Agreement (CA): Celgene Corporation; Speakers Bureau (SB): Celgene Corporation, Millennium Pharmaceuticals Inc. Dr Lonial — CA: Celgene Corporation, Millennium Pharmaceuticals Inc, Ortho Biotech Products LP. Dr Orlowski — AC: Amgen Inc, Celgene Corporation, Millennium Pharmaceuticals Inc, Ortho Biotech Products LP. Dr Richardson — AC and SB: Celgene Corporation, Millennium Pharmaceuticals Inc.
COMMUNITY ONCOLOGIST PANEL
Drs Bobrow, Deutsch, Dresdner, Freedman, Glynn, Harwin, Hoffman, Levy, Lo, Merchant, Moriarty, Schnell, Schwartz and Taylor had no real or apparent conflicts of interest to disclose. The following physicians (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Bhardwaj — AC: Celgene Corporation, Genentech BioOncology; CA: Novartis Pharmaceuticals Corporation; Paid Research (PR): Genentech BioOncology; Stock Ownership (SO): Celgene Corporation. Dr Drullinsky — SB: Novartis Pharmaceuticals Corporation. Dr Farber — AC: Biogen Idec, Genentech BioOncology; SB: Alexion Pharmaceuticals, Bayer Pharmaceuticals Corporation, Centocor Ortho Biotech Services. Dr Gearhart — SB: Eli Lilly and Company, Sanofi-Aventis. Dr Hart — SB: GlaxoSmithKline. Dr Hussein — AC: Bayer Pharmaceuticals Corporation, Roche Laboratories Inc; SB: Amgen Inc, Novartis Pharmaceuticals Corporation, Sanofi-Aventis. Dr Moss — AC: Celgene Corporation, Millennium Pharmaceuticals Inc, Pharmion Corporation; PR: Abraxis BioScience, Amgen Inc, Archimedes Development Limited, Eisai Inc, Genentech BioOncology, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, Pharmatech Inc, Sanofi-Aventis, Taiho Pharmaceutical Co Ltd. Dr Pizzolato — AC: Celgene Corporation; SB: ImClone Systems Incorporated, Sanofi-Aventis. Dr Sabbath — AC: Bristol-Myers Squibb Company; SB: Amgen Inc; SO: Amgen Inc, Celgene Corporation, GlaxoSmithKline, Novartis Pharmaceuticals Corporation. Dr Seigel — SO: AstraZeneca Pharmaceuticals LP, Celgene Corporation, Genentech BioOncology, Millennium Pharmaceuticals Inc. Dr Vacirca — SB: Abraxis BioScience, OSI Pharmaceuticals Inc, Sanofi-Aventis.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS
The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.
FACULTY | ||
Andrzej J Jakubowiak, MD, PhD Associate Professor Director, Myeloma Program The University of Michigan Comprehensive Cancer Center Division of Hematology/Oncology Ann Arbor, Michigan Sagar Lonial, MD Associate Professor Director of Translational Research B-Cell Malignancy Program Department of Medical Oncology and Hematology Winship Cancer Institute Emory University School of Medicine Atlanta, Georgia |
Robert Z Orlowski, MD, PhD Director, Department of Lymphoma and Myeloma Associate Professor Department of Experimental Therapeutics Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, Texas Paul G Richardson, MD Associate Professor of Medicine Harvard Medical School Clinical Director of the Jerome Lipper Center for Multiple Myeloma Dana-Farber Cancer Institute Boston, Massachusetts |
|
COMMUNITY ONCOLOGIST PANEL | ||
Sushil Bhardwaj, MD Samuel N Bobrow, MD Margaret A Deutsch, MD David M Dresdner, MD Pamela R Drullinsky, MD Charles M Farber, MD, PhD Allan Freedman, MD Bonni L Gearhart, MD Philip T Glynn, MD Lowell Hart, MD |
William N Harwin, MD Kenneth R Hoffman, MD, MPH Atif M Hussein, MD, MMM Isaac Levy, MD K M Steve Lo, MD Noor M Merchant, MD Daniel J Moriarty, MD Robert A Moss, MD Joseph F Pizzolato, MD Kert D Sabbath, MD Frederick M Schnell, MD Michael A Schwartz, MD Leonard J Seigel, MD Mark Taylor, MD Jeffrey L Vacirca, MD |
|
Table of Contents | Top of Page |